AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dibiglim MF 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Novartis India Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Dibiglim MF 2mg/500mg Tablet

Glucoduo 2mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This treatment helps regulate blood glucose in diabetic patients. Glucoduo 2mg/500mg tablets should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan involving diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headaches, and tremors. Regular meals and readily available glucose sources (sugary foods or juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to track blood cell counts and liver function.

Uses of Dibiglim MF 2mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Dibiglim MF 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Dibiglim MF 2mg/500mg Tablet should be administered with food.

Common Side effects of Dibiglim MF 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Dibiglim MF 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 2mg/500mg Dibiglim MF tablet whole; do not damage it by chewing, crushing, or breaking. It should be administered with a meal.

How Dibiglim MF 2mg/500mg Tablet works:

Dibiglim MF 2mg/500mg tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Dibiglim MF 2mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Dibiglim MF 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

The use of Dibiglim MF 2mg/500mg tablets while breastfeeding is contraindicated due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with kidney impairment should use Dibiglim MF 2mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Dibiglim MF 2mg/500mg tablets. Physician consultation is essential. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Dibiglim MF 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation at a low dose is typical; however, the medication is unsuitable for individuals with severe hepatic dysfunction.

What if you forget to take Dibiglim MF 2mg/500mg Tablet :

Should you forget a dose of Dibiglim MF 2mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dibiglim MF 2mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Dibiglim MF 2mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely, ensuring it's inaccessible to children, pets, and others.
Dibiglim MF 2mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excess blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). While rare, this risk is heightened in patients with kidney disease, older adults, and those who consume excessive alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue use and seek immediate medical attention.
Dibiglim MF 2mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Dibiglim MF 2mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Dibiglim MF 2mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and balance problems (ataxia). To mitigate these risks, supplemental vitamin B12 is recommended annually by some researchers.
Dibiglim MF 2mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Dibiglim MF 2mg/500mg Tablet with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Dibiglim MF 2mg/500mg Tab...
43
MRP 52
17% off